Why Piercers Should Understand Keloid Management
As piercers, we often encounter clients concerned about post-piercing bumps. While hypertrophic scars may settle on their own, true keloids require medical attention. Understanding the available clinical treatments. Especially intralesional corticosteroid injections and helps us support clients with knowledge and empathy.
Clinical Overview
Intralesional corticosteroid injection (ILC) involves injecting triamcinolone acetonide (TA) directly into the fibrous scar tissue. This method suppresses fibroblast overactivity and collagen overproduction, softening the keloid and preventing regrowth. Typical concentration: 20–40 mg/mL Typical volume: 0.1–1.0 mL per session, depending on lesion size.
Study Insight: Yonsei University, 2009
A Korean study by Jung et al. (Ann Dermatol, 21 (3): 221–225) reviewed 18 earlobe keloids from 15 female patients caused by ear piercings. Protocol Summary: Pre-operative: Two TA injections at 1-month intervals. Surgical step: Complete excision with tension-free closure. Post-operative: Monthly TA injections (20–40 mg/mL) starting 2 weeks after surgery. Follow-up: 4–42 months (mean 18.5 months). Outcomes: Good aesthetic results — 61% Fair — 22% Recurrence — 16.6% No atrophy or telangiectasia noted sa-server-file-api-user-upload This combination approach proved far more effective than excision alone (recurrence 45–100%).
What This Means for Piercers
While injection therapy is performed by medical professionals, piercers play an essential educational role: Identify early signs of hypertrophic vs. keloid scarring Encourage timely dermatology referral Avoid re-piercing through scarred tissue Reinforce aftercare routines that reduce inflammation and pressure Empowered clients make safer decisions—and trust piercers who understand the science behind healing.
Professional Takeaways
ILC remains the standard adjunctive therapy for earlobe keloids. Surgery + repeated triamcinolone injections yields < 20 % recurrence. Side effects are minimal when dosing intervals are properly spaced. Persistent or recurrent cases may combine ILC with silicone pressure devices or low-dose radiotherapy.
After completing all injection sessions, Debbie’s doctor advised stopping further treatment because the injections had caused a concave area on her ear. When I touch the ear, I can feel a deep indentation, almost down to the bone. Some of the ear’s fatty tissue is missing, and any re-piercing could lead to distortion and recurrent scarring.
✦ Continue Learning & Build Expertise
🧠 Explore more clinical insights and aftercare strategies: Read All Piercer Education Posts → 💎 Looking to upgrade your jewelry selection?
Shop Professional-Grade Jewelry
Reference: Jung J.Y., Roh M.R., Kwon Y.S., & Chung K.Y. (2009). Surgery and Perioperative Intralesional Corticosteroid Injection for Treating Earlobe Keloids: A Korean Experience. Annals of Dermatology, 21(3), 221–225
0 comments